Lv41
620 积分 2022-12-19 加入
Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes
2小时前
已完结
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial
2小时前
已完结
Clinical pharmacology of glucagon-like peptide-1 receptor agonists
2小时前
已完结
Glucagon‐like peptide‐1 reduces hepatic glucose production indirectly through insulin and glucagon in humans
2小时前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with Richter transformation (RT) from the Center for International Blood and Marrow Transplant Research (CIBMTR)
5个月前
已关闭
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
8个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma
1年前
已完结
Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis.附件
1年前
已关闭
皖公网安备34019202002308
